Client

A multinational pharmaceutical company operating R&D centers, manufacturing plants, and distribution networks across 40+ countries.

Client Background

The organization manages sensitive research data, clinical trial records, patient information, and IP-driven assets. With a rapidly expanding digital footprint and increasing cyber threats targeting healthcare and pharma sectors, the client needed a security foundation that protected its most critical operations end-to-end.

Client Challenge

The company’s security posture was constrained by legacy IAM, inconsistent access controls, and fragmented security tools across global sites. Remote research teams accessed sensitive systems through outdated VPN models, increasing insider and external threat exposure.
Manufacturing systems lacked layered identity verification, creating vulnerabilities across OT/IT interfaces. Regulatory audits (GDPR, HIPAA, regional medical compliance) repeatedly highlighted gaps in governance, privileged access, and data residency.
The organization needed to adopt a Zero Trust model that unified identity, network segmentation, continuous authentication, and real-time monitoring without disrupting mission-critical R&D or manufacturing operations.

Xevyte Solution

Xevyte executed a global Zero Trust transformation using a multi-layered cybersecurity architecture. The program began with identity baseline assessment, access governance mapping, and micro-segmentation strategy across cloud, on-prem, and OT environments.
CENTRA (IAM) was deployed to unify identity access, enforce MFA/SSO, and establish full lifecycle governance for employees, contractors, and partner ecosystems.
Network segmentation and continuous authentication were implemented across R&D labs, manufacturing networks, and cloud workloads. VIGIL (SIEM) provided real-time threat correlation, while PRAETOR (EDR) delivered proactive endpoint defense for research teams handling sensitive IP. Automated enforcement workflows were integrated using AUTON (SOAR) to streamline incident response.

Business Impact

• 97% reduction in unauthorized access attempts
• Zero Trust controls strengthened IP and clinical data protection
• Unified identity governance across 40+ global sites
• Faster compliance readiness for regulatory audits
• Significant reduction in insider-threat risk due to continuous authentication

Key Capabilities Delivered

• Zero Trust Security Architecture
• Identity Governance via CENTRA
• Enterprise SIEM + EDR Integration
• Network & Application Segmentation
• Automated Threat Response (SOAR)
• OT/IT Security Alignment